Neuropeptide Y Overexpressing Female and Male Mice Show Divergent Metabolic but Not Gut Microbial Responses to Prenatal Metformin Exposure

• Henriikka Salomäki-Myftari,

  Affiliations Institute of Biomedicine, Department of Pharmacology, Drug Development and Therapeutics, University of Turku, Turku, Finland, Drug Research Doctoral Programme (DRDP), University of Turku, Turku, Finland

  ⨯
• Laura H. Vähätalo,

  Affiliations Institute of Biomedicine, Department of Pharmacology, Drug Development and Therapeutics, University of Turku, Turku, Finland, Drug Research Doctoral Programme (DRDP), University of Turku, Turku, Finland

  ⨯
• Liisa Ailanen,

  Affiliations Institute of Biomedicine, Department of Pharmacology, Drug Development and Therapeutics, University of Turku, Turku, Finland, Drug Research Doctoral Programme (DRDP), University of Turku, Turku, Finland

  ⨯
• Sami Pietilä,

  Affiliation Bioinformatics Unit, Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland

  ⨯
• Asta Laiho,

  Affiliation Bioinformatics Unit, Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland

  ⨯
• Arno Hänninen,

  Affiliation Institute of Biomedicine, Department of Medical Microbiology and Immunology, University of Turku, Turku, Finland

  ⨯
• Juha-Pekka Pursiheimo,

  Affiliation Turku Clinical Sequencing Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland

  ⨯
• Eveliina Munukka,

  Affiliation Institute of Biomedicine, Department of Medical Microbiology and Immunology, University of Turku, Turku, Finland

  ⨯
• Anniina Rintala,

  Affiliation Institute of Biomedicine, Department of Medical Microbiology and Immunology, University of Turku, Turku, Finland

  ⨯
• Eriika Savontaus,

  Affiliation Institute of Biomedicine, Department of Pharmacology, Drug Development and Therapeutics, University of Turku, Turku, Finland

  ⨯
• Ullamari Pesonen,

  Affiliation Institute of Biomedicine, Department of Pharmacology, Drug Development and Therapeutics, University of Turku, Turku, Finland

  ⨯
• Markku Koulu

  * E-mail: markku.koulu@utu.fi

  Affiliation Institute of Biomedicine, Department of Pharmacology, Drug Development and Therapeutics, University of Turku, Turku, Finland

  ⨯